Phenol, 3-(1H-indol-4-yl)-5-(3-pyridinylamino)- Struktur

Phenol, 3-(1H-indol-4-yl)-5-(3-pyridinylamino)-

Bezeichnung:Phenol, 3-(1H-indol-4-yl)-5-(3-pyridinylamino)-

CAS-Nr915410-98-9

Englisch Name:Phenol, 3-(1H-indol-4-yl)-5-(3-pyridinylamino)-

CBNumberCB68736905

SummenformelC19H15N3O

Molgewicht301.34

MOL-Datei915410-98-9.mol

Phenol, 3-(1H-indol-4-yl)-5-(3-pyridinylamino)- physikalisch-chemischer Eigenschaften

Siedepunkt	598.8±50.0 °C(Predicted)
Dichte	1.340±0.06 g/cm3(Predicted)
pka	9.60±0.10(Predicted)

Phenol, 3-(1H-indol-4-yl)-5-(3-pyridinylamino)- Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung
OUN10989, an analogue compound of LP-261, is a Potent Antimitotic Agent. OUN10989 exhibited potent inhibition of mitosis at the G2/M stage. OUN10989 was first reported in J. Med. Chem 54(1), 179-200; 2011 (compound 7). This product has no formal name at the moment.
in vitro
The synthesis and optimization of a series of orally bioavailable 1-(1H-indol-4-yl)-3,5-disubstituted benzene analogues as antimitotic agents are described. A functionalized dibromobenzene intermediate was used as a key scaffold, which when modified by sequential Suzuki coupling and Buchwald-Hartwig amination provided a flexible entry to 1,3,5-trisubstituted phenyl compounds. A 1H-indol-4-yl moiety at the 1-position was determined to be a critical feature for optimal potency. The compounds have been shown to induce cell cycle arrest at the G2/M phase and demonstrate efficacy in both cell viability and cell proliferation assays. The primary site of action for these agents is revealed by their colchicine competitive inhibition of tubulin polymerization, and a computational model has been developed for the association of these compounds to tubulin. An optimized lead LP-261 significantly inhibits growth of a human non-small-cell lung tumor (NCI-H522) in a mouse xenograft model._x000D_ _x000D_ Reference: Shetty RS, Lee Y, Liu B, Husain A, Joseph RW, Lu Y, Nelson D, Mihelcic J, Chao W, Moffett KK, Schumacher A, Flubacher D, Stojanovic A, Bukhtiyarova M, Williams K, Lee KJ, Ochman AR, Saporito MS, Moore WR, Flynn GA, Dorsey BD, Springman EB, Fujimoto T, Kelly MJ. Synthesis and pharmacological evaluation of N-(3-(1H-indol-4-yl)-5-(2-methoxyisonicotinoyl)phenyl)methanesulfonamide (LP-261), a potent antimitotic agent. J Med Chem. 2011 Jan 13;54(1):179-200. doi: 10.1021/jm100659v. Epub 2010 Dec 2. PMID: 21126027.
target
OUN10989, an analogue compound of LP-261, is a Potent Antimitotic Agent.

Phenol, 3-(1H-indol-4-yl)-5-(3-pyridinylamino)- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Send Inquriy